In March 2025, the company introduced new options for any direct-to-purchaser supplying of its Wegovy weight loss drug. The company proven a whole new pharmacy, termed NovoCare, which would cost prospects $499 per month for entry to the drug, below fifty percent the cost of the drug through othe